non-small cell lung cancer
Conditions
Interventions
adjuvant therapy (targeted therapy):None
observation group:None
Sponsors
Hainan hospitalof People 's Liberation Army General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Sublobectomy (wedge resection or segmentectomy)/lobectomy with lymph node sampling or dissection (R0 resection);(2) preoperative CT scan suggests subsolid nodules (CTR>0.5) or solid nodules; (3) Postoperative pathology is adenocarcinoma, staged as IB according to the 8th edition of UICC/AJCC; (4) Genetic testing of tumor tissue suggests deletion of exon 19 and exon L858R point mutation in exon 21, with or without other EGFR mutations
Exclusion criteria
Exclusion criteria: (1) Preoperative CT suggests pure ground glass nodules or subsolid nodules with a ground glass component greater than 50%; (2) neoadjuvant chemoradiotherapy or targeted therapy before surgery; (3) postoperative pathology is squamous cell carcinoma, carcinoma in situ, micro-invasive carcinoma, metastatic carcinoma and other types of tumors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year disease-free survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| 3-year disease-free survival;5 year overall survival; | — |
Countries
china
Contacts
Public Contactshen leilei
Hainan hospitalof People 's Liberation Army General Hospital
Outcome results
None listed